Sep 9 2009
Renato Corporation (FRANKFURT/exchange>: 4OZ) has entered into negotiations to acquire up to 50% of Vanguard Pharmaceutical Corporation. "By acquiring Vanguard, Renato Corporation will have an existing infrastructure in place to market its generic pharmaceuticals to Latin and South America," said Mr. Morkunas.
Mr. Morkunas further states, "Our second phase corporate growth development is to build generic biotech companies in developing countries using North American manufacturing standards." Vanguard Pharmaceutical Corporation is a natural integral part of Renato's strategic expansion program.